nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—CYP3A5—Dapsone—systemic lupus erythematosus	0.0353	0.0603	CbGbCtD
Lapatinib—CYP2C8—Dapsone—systemic lupus erythematosus	0.0339	0.058	CbGbCtD
Lapatinib—CYP3A5—Mycophenolate mofetil—systemic lupus erythematosus	0.0306	0.0523	CbGbCtD
Lapatinib—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0294	0.0503	CbGbCtD
Lapatinib—CYP2C19—Dapsone—systemic lupus erythematosus	0.0285	0.0487	CbGbCtD
Lapatinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0263	0.0449	CbGbCtD
Lapatinib—CYP3A5—Hydrocortisone—systemic lupus erythematosus	0.0245	0.042	CbGbCtD
Lapatinib—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.0236	0.0404	CbGbCtD
Lapatinib—CYP3A5—Cyclosporine—systemic lupus erythematosus	0.0232	0.0396	CbGbCtD
Lapatinib—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.0223	0.0381	CbGbCtD
Lapatinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0199	0.034	CbGbCtD
Lapatinib—CYP2C19—Prednisone—systemic lupus erythematosus	0.0197	0.0337	CbGbCtD
Lapatinib—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0187	0.032	CbGbCtD
Lapatinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.0171	0.0292	CbGbCtD
Lapatinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.0169	0.0288	CbGbCtD
Lapatinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.016	0.0273	CbGbCtD
Lapatinib—ABCB1—Prednisone—systemic lupus erythematosus	0.0159	0.0272	CbGbCtD
Lapatinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0157	0.0269	CbGbCtD
Lapatinib—CYP3A5—Dexamethasone—systemic lupus erythematosus	0.0153	0.0261	CbGbCtD
Lapatinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0151	0.0258	CbGbCtD
Lapatinib—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.0147	0.0251	CbGbCtD
Lapatinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.0138	0.0235	CbGbCtD
Lapatinib—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0123	0.0211	CbGbCtD
Lapatinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0119	0.0204	CbGbCtD
Lapatinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0119	0.0204	CbGbCtD
Lapatinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0102	0.0175	CbGbCtD
Lapatinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0101	0.0173	CbGbCtD
Lapatinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00993	0.017	CbGbCtD
Lapatinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00957	0.0164	CbGbCtD
Lapatinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00953	0.0163	CbGbCtD
Lapatinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00904	0.0155	CbGbCtD
Lapatinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00798	0.0137	CbGbCtD
Lapatinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00595	0.0102	CbGbCtD
Lapatinib—TAP1—nephron tubule—systemic lupus erythematosus	0.0039	0.0419	CbGeAlD
Lapatinib—PIK3C2B—nephron tubule—systemic lupus erythematosus	0.00366	0.0393	CbGeAlD
Lapatinib—TAP1—cortex of kidney—systemic lupus erythematosus	0.00334	0.0358	CbGeAlD
Lapatinib—CYP2C19—urine—systemic lupus erythematosus	0.00329	0.0353	CbGeAlD
Lapatinib—PIK3C2B—cortex of kidney—systemic lupus erythematosus	0.00313	0.0336	CbGeAlD
Lapatinib—ERBB2—connective tissue—systemic lupus erythematosus	0.00294	0.0315	CbGeAlD
Lapatinib—TAP1—tendon—systemic lupus erythematosus	0.00277	0.0297	CbGeAlD
Lapatinib—TAP1—bone marrow—systemic lupus erythematosus	0.00268	0.0288	CbGeAlD
Lapatinib—PI4KB—nephron tubule—systemic lupus erythematosus	0.00267	0.0286	CbGeAlD
Lapatinib—ERBB2—skin of body—systemic lupus erythematosus	0.00265	0.0285	CbGeAlD
Lapatinib—PIK3C2B—tendon—systemic lupus erythematosus	0.0026	0.0279	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—systemic lupus erythematosus	0.00251	0.027	CbGeAlD
Lapatinib—ERBB2—kidney—systemic lupus erythematosus	0.0025	0.0269	CbGeAlD
Lapatinib—ERBB4—cortex of kidney—systemic lupus erythematosus	0.00244	0.0262	CbGeAlD
Lapatinib—TAP1—lung—systemic lupus erythematosus	0.00243	0.0261	CbGeAlD
Lapatinib—PI4KB—kidney—systemic lupus erythematosus	0.00234	0.0252	CbGeAlD
Lapatinib—PI4KB—cortex of kidney—systemic lupus erythematosus	0.00228	0.0245	CbGeAlD
Lapatinib—PIK3C2B—lung—systemic lupus erythematosus	0.00228	0.0245	CbGeAlD
Lapatinib—PIK3C2B—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.00221	0.333	CbGdCrCtD
Lapatinib—ERBB2—lymphoid tissue—systemic lupus erythematosus	0.00215	0.0231	CbGeAlD
Lapatinib—PIK3C2B—nervous system—systemic lupus erythematosus	0.00211	0.0227	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—systemic lupus erythematosus	0.00203	0.0218	CbGeAlD
Lapatinib—ERBB4—tendon—systemic lupus erythematosus	0.00202	0.0217	CbGeAlD
Lapatinib—CYP3A4—urine—systemic lupus erythematosus	0.00195	0.0209	CbGeAlD
Lapatinib—PI4KB—tendon—systemic lupus erythematosus	0.00189	0.0203	CbGeAlD
Lapatinib—PI4KB—bone marrow—systemic lupus erythematosus	0.00183	0.0197	CbGeAlD
Lapatinib—ERBB2—lung—systemic lupus erythematosus	0.00177	0.019	CbGeAlD
Lapatinib—ERBB4—lung—systemic lupus erythematosus	0.00177	0.019	CbGeAlD
Lapatinib—CYP2C19—blood plasma—systemic lupus erythematosus	0.00172	0.0184	CbGeAlD
Lapatinib—PI4KB—lung—systemic lupus erythematosus	0.00166	0.0178	CbGeAlD
Lapatinib—ERBB2—nervous system—systemic lupus erythematosus	0.00164	0.0176	CbGeAlD
Lapatinib—ERBB4—nervous system—systemic lupus erythematosus	0.00164	0.0176	CbGeAlD
Lapatinib—ERBB4—central nervous system—systemic lupus erythematosus	0.00158	0.017	CbGeAlD
Lapatinib—ERBB2—central nervous system—systemic lupus erythematosus	0.00158	0.017	CbGeAlD
Lapatinib—PI4KB—nervous system—systemic lupus erythematosus	0.00154	0.0165	CbGeAlD
Lapatinib—EGFR—lung—systemic lupus erythematosus	0.0015	0.0161	CbGeAlD
Lapatinib—CYP2C8—blood plasma—systemic lupus erythematosus	0.0015	0.0161	CbGeAlD
Lapatinib—PI4KB—central nervous system—systemic lupus erythematosus	0.00148	0.0159	CbGeAlD
Lapatinib—CYP3A5—blood plasma—systemic lupus erythematosus	0.00135	0.0145	CbGeAlD
Lapatinib—CYP3A4—blood plasma—systemic lupus erythematosus	0.00102	0.0109	CbGeAlD
Lapatinib—ABCB1—blood plasma—systemic lupus erythematosus	0.000719	0.00772	CbGeAlD
Lapatinib—CYP3A5—nephron tubule—systemic lupus erythematosus	0.000698	0.0075	CbGeAlD
Lapatinib—CYP2C8—kidney—systemic lupus erythematosus	0.00068	0.0073	CbGeAlD
Lapatinib—CYP3A5—kidney—systemic lupus erythematosus	0.000613	0.00659	CbGeAlD
Lapatinib—CYP3A5—cortex of kidney—systemic lupus erythematosus	0.000597	0.00641	CbGeAlD
Lapatinib—CYP3A4—kidney—systemic lupus erythematosus	0.00046	0.00494	CbGeAlD
Lapatinib—CYP3A5—lung—systemic lupus erythematosus	0.000435	0.00467	CbGeAlD
Lapatinib—ABCB1—nephron tubule—systemic lupus erythematosus	0.000371	0.00398	CbGeAlD
Lapatinib—PIK3C2B—Exemestane—Methylprednisolone—systemic lupus erythematosus	0.000342	0.0514	CbGdCrCtD
Lapatinib—ABCB1—kidney—systemic lupus erythematosus	0.000326	0.0035	CbGeAlD
Lapatinib—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000317	0.00341	CbGeAlD
Lapatinib—PIK3C2B—Exemestane—Prednisone—systemic lupus erythematosus	0.000312	0.0469	CbGdCrCtD
Lapatinib—PIK3C2B—Exemestane—Prednisolone—systemic lupus erythematosus	0.000305	0.0458	CbGdCrCtD
Lapatinib—CYP3A4—nervous system—systemic lupus erythematosus	0.000302	0.00324	CbGeAlD
Lapatinib—CYP3A4—central nervous system—systemic lupus erythematosus	0.000291	0.00312	CbGeAlD
Lapatinib—ERBB2—Exemestane—Methylprednisolone—systemic lupus erythematosus	0.000282	0.0423	CbGdCrCtD
Lapatinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.00028	0.00301	CbGeAlD
Lapatinib—ERBB2—Exemestane—Prednisone—systemic lupus erythematosus	0.000257	0.0386	CbGdCrCtD
Lapatinib—ABCB1—bone marrow—systemic lupus erythematosus	0.000255	0.00274	CbGeAlD
Lapatinib—Skin disorder—Cyclosporine—systemic lupus erythematosus	0.000255	0.00186	CcSEcCtD
Lapatinib—Angiopathy—Dexamethasone—systemic lupus erythematosus	0.000254	0.00186	CcSEcCtD
Lapatinib—Angiopathy—Betamethasone—systemic lupus erythematosus	0.000254	0.00186	CcSEcCtD
Lapatinib—Infection—Mycophenolate mofetil—systemic lupus erythematosus	0.000254	0.00186	CcSEcCtD
Lapatinib—Nervous system disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000251	0.00183	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisolone—systemic lupus erythematosus	0.000251	0.0377	CbGdCrCtD
Lapatinib—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.00025	0.00183	CcSEcCtD
Lapatinib—Anorexia—Cyclosporine—systemic lupus erythematosus	0.00025	0.00183	CcSEcCtD
Lapatinib—Skin disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000248	0.00181	CcSEcCtD
Lapatinib—Alopecia—Dexamethasone—systemic lupus erythematosus	0.000248	0.00181	CcSEcCtD
Lapatinib—Alopecia—Betamethasone—systemic lupus erythematosus	0.000248	0.00181	CcSEcCtD
Lapatinib—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000246	0.0018	CcSEcCtD
Lapatinib—Anorexia—Mycophenolate mofetil—systemic lupus erythematosus	0.000244	0.00178	CcSEcCtD
Lapatinib—Asthenia—Leflunomide—systemic lupus erythematosus	0.000244	0.00178	CcSEcCtD
Lapatinib—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000243	0.00178	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—systemic lupus erythematosus	0.000241	0.00176	CcSEcCtD
Lapatinib—Pruritus—Leflunomide—systemic lupus erythematosus	0.00024	0.00176	CcSEcCtD
Lapatinib—Connective tissue disorder—Prednisone—systemic lupus erythematosus	0.00024	0.00175	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000239	0.00174	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisolone—systemic lupus erythematosus	0.000239	0.00174	CcSEcCtD
Lapatinib—Neutropenia—Methotrexate—systemic lupus erythematosus	0.000238	0.00174	CcSEcCtD
Lapatinib—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000237	0.00173	CcSEcCtD
Lapatinib—Cough—Triamcinolone—systemic lupus erythematosus	0.000235	0.00171	CcSEcCtD
Lapatinib—Dyspnoea—Cyclosporine—systemic lupus erythematosus	0.000234	0.00171	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000233	0.0017	CcSEcCtD
Lapatinib—Anaphylactic shock—Hydrocortisone—systemic lupus erythematosus	0.000233	0.0017	CcSEcCtD
Lapatinib—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000232	0.0017	CcSEcCtD
Lapatinib—Infection—Hydrocortisone—systemic lupus erythematosus	0.000232	0.00169	CcSEcCtD
Lapatinib—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000231	0.00169	CcSEcCtD
Lapatinib—ABCB1—lung—systemic lupus erythematosus	0.000231	0.00248	CbGeAlD
Lapatinib—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000231	0.00169	CcSEcCtD
Lapatinib—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000229	0.00167	CcSEcCtD
Lapatinib—Vomiting—Azathioprine—systemic lupus erythematosus	0.000229	0.00167	CcSEcCtD
Lapatinib—Nervous system disorder—Hydrocortisone—systemic lupus erythematosus	0.000229	0.00167	CcSEcCtD
Lapatinib—Pneumonia—Methotrexate—systemic lupus erythematosus	0.000229	0.00167	CcSEcCtD
Lapatinib—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000228	0.00167	CcSEcCtD
Lapatinib—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000228	0.00167	CcSEcCtD
Lapatinib—Dyspnoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000228	0.00167	CcSEcCtD
Lapatinib—Decreased appetite—Cyclosporine—systemic lupus erythematosus	0.000228	0.00166	CcSEcCtD
Lapatinib—Infestation—Methotrexate—systemic lupus erythematosus	0.000227	0.00166	CcSEcCtD
Lapatinib—Infestation NOS—Methotrexate—systemic lupus erythematosus	0.000227	0.00166	CcSEcCtD
Lapatinib—Rash—Azathioprine—systemic lupus erythematosus	0.000227	0.00166	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	0.000227	0.00166	CcSEcCtD
Lapatinib—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000227	0.00165	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000226	0.00165	CcSEcCtD
Lapatinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	0.000226	0.00165	CcSEcCtD
Lapatinib—Fatigue—Cyclosporine—systemic lupus erythematosus	0.000226	0.00165	CcSEcCtD
Lapatinib—Headache—Azathioprine—systemic lupus erythematosus	0.000225	0.00165	CcSEcCtD
Lapatinib—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000225	0.00164	CcSEcCtD
Lapatinib—Constipation—Cyclosporine—systemic lupus erythematosus	0.000224	0.00164	CcSEcCtD
Lapatinib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	0.000222	0.00162	CcSEcCtD
Lapatinib—Anorexia—Hydrocortisone—systemic lupus erythematosus	0.000222	0.00162	CcSEcCtD
Lapatinib—Stomatitis—Methotrexate—systemic lupus erythematosus	0.000221	0.00162	CcSEcCtD
Lapatinib—Angiopathy—Prednisone—systemic lupus erythematosus	0.000221	0.00162	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000221	0.00161	CcSEcCtD
Lapatinib—Immune system disorder—Prednisone—systemic lupus erythematosus	0.00022	0.00161	CcSEcCtD
Lapatinib—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	0.000219	0.0016	CcSEcCtD
Lapatinib—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	0.000219	0.0016	CcSEcCtD
Lapatinib—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000219	0.0016	CcSEcCtD
Lapatinib—Infection—Triamcinolone—systemic lupus erythematosus	0.000218	0.00159	CcSEcCtD
Lapatinib—Infection—Methylprednisolone—systemic lupus erythematosus	0.000218	0.00159	CcSEcCtD
Lapatinib—Vomiting—Leflunomide—systemic lupus erythematosus	0.000216	0.00158	CcSEcCtD
Lapatinib—Insomnia—Prednisolone—systemic lupus erythematosus	0.000216	0.00158	CcSEcCtD
Lapatinib—Alopecia—Prednisone—systemic lupus erythematosus	0.000216	0.00157	CcSEcCtD
Lapatinib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	0.000215	0.00157	CcSEcCtD
Lapatinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	0.000215	0.00157	CcSEcCtD
Lapatinib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	0.000214	0.00157	CcSEcCtD
Lapatinib—Epistaxis—Methotrexate—systemic lupus erythematosus	0.000214	0.00156	CcSEcCtD
Lapatinib—Rash—Leflunomide—systemic lupus erythematosus	0.000214	0.00156	CcSEcCtD
Lapatinib—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000214	0.00156	CcSEcCtD
Lapatinib—Mental disorder—Prednisone—systemic lupus erythematosus	0.000214	0.00156	CcSEcCtD
Lapatinib—ABCB1—nervous system—systemic lupus erythematosus	0.000214	0.0023	CbGeAlD
Lapatinib—Nausea—Azathioprine—systemic lupus erythematosus	0.000214	0.00156	CcSEcCtD
Lapatinib—Headache—Leflunomide—systemic lupus erythematosus	0.000213	0.00155	CcSEcCtD
Lapatinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	0.000213	0.00155	CcSEcCtD
Lapatinib—Malnutrition—Prednisone—systemic lupus erythematosus	0.000212	0.00155	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000212	0.00155	CcSEcCtD
Lapatinib—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.000211	0.00154	CcSEcCtD
Lapatinib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000209	0.00153	CcSEcCtD
Lapatinib—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000208	0.00152	CcSEcCtD
Lapatinib—Myalgia—Betamethasone—systemic lupus erythematosus	0.000208	0.00152	CcSEcCtD
Lapatinib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	0.000207	0.00151	CcSEcCtD
Lapatinib—ABCB1—central nervous system—systemic lupus erythematosus	0.000206	0.00221	CbGeAlD
Lapatinib—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.000205	0.0015	CcSEcCtD
Lapatinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000203	0.00148	CcSEcCtD
Lapatinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000202	0.00148	CcSEcCtD
Lapatinib—Nausea—Leflunomide—systemic lupus erythematosus	0.000202	0.00147	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000201	0.00147	CcSEcCtD
Lapatinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000201	0.00147	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.0002	0.00146	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000199	0.00146	CcSEcCtD
Lapatinib—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000199	0.00145	CcSEcCtD
Lapatinib—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000199	0.00145	CcSEcCtD
Lapatinib—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000198	0.00145	CcSEcCtD
Lapatinib—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000198	0.00145	CcSEcCtD
Lapatinib—Infection—Betamethasone—systemic lupus erythematosus	0.000198	0.00144	CcSEcCtD
Lapatinib—Infection—Dexamethasone—systemic lupus erythematosus	0.000198	0.00144	CcSEcCtD
Lapatinib—Anaemia—Prednisone—systemic lupus erythematosus	0.000196	0.00143	CcSEcCtD
Lapatinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000196	0.00143	CcSEcCtD
Lapatinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000195	0.00143	CcSEcCtD
Lapatinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000195	0.00143	CcSEcCtD
Lapatinib—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000193	0.00141	CcSEcCtD
Lapatinib—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000193	0.00141	CcSEcCtD
Lapatinib—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000193	0.00141	CcSEcCtD
Lapatinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000191	0.00139	CcSEcCtD
Lapatinib—Anorexia—Dexamethasone—systemic lupus erythematosus	0.00019	0.00139	CcSEcCtD
Lapatinib—Anorexia—Betamethasone—systemic lupus erythematosus	0.00019	0.00139	CcSEcCtD
Lapatinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000189	0.00138	CcSEcCtD
Lapatinib—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000189	0.00138	CcSEcCtD
Lapatinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000189	0.00138	CcSEcCtD
Lapatinib—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000188	0.00138	CcSEcCtD
Lapatinib—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000188	0.00137	CcSEcCtD
Lapatinib—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000186	0.00135	CcSEcCtD
Lapatinib—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000185	0.00135	CcSEcCtD
Lapatinib—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000184	0.00135	CcSEcCtD
Lapatinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000184	0.00135	CcSEcCtD
Lapatinib—PIK3C2B—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	0.000184	0.0276	CbGdCrCtD
Lapatinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000184	0.00134	CcSEcCtD
Lapatinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000184	0.00134	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000181	0.00132	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000181	0.00132	CcSEcCtD
Lapatinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000181	0.00132	CcSEcCtD
Lapatinib—Myalgia—Prednisone—systemic lupus erythematosus	0.000181	0.00132	CcSEcCtD
Lapatinib—Arthralgia—Prednisone—systemic lupus erythematosus	0.000181	0.00132	CcSEcCtD
Lapatinib—Alopecia—Methotrexate—systemic lupus erythematosus	0.00018	0.00132	CcSEcCtD
Lapatinib—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00018	0.00131	CcSEcCtD
Lapatinib—Insomnia—Betamethasone—systemic lupus erythematosus	0.00018	0.00131	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.00018	0.00131	CcSEcCtD
Lapatinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000179	0.00131	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000179	0.00131	CcSEcCtD
Lapatinib—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000179	0.0013	CcSEcCtD
Lapatinib—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000178	0.0013	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000176	0.00128	CcSEcCtD
Lapatinib—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000175	0.00128	CcSEcCtD
Lapatinib—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000175	0.00128	CcSEcCtD
Lapatinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000175	0.00128	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000173	0.00127	CcSEcCtD
Lapatinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000173	0.00126	CcSEcCtD
Lapatinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000173	0.00126	CcSEcCtD
Lapatinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000173	0.00126	CcSEcCtD
Lapatinib—Infection—Prednisone—systemic lupus erythematosus	0.000172	0.00126	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000172	0.00126	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000172	0.00126	CcSEcCtD
Lapatinib—Back pain—Methotrexate—systemic lupus erythematosus	0.000172	0.00125	CcSEcCtD
Lapatinib—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000172	0.00125	CcSEcCtD
Lapatinib—Fatigue—Betamethasone—systemic lupus erythematosus	0.000172	0.00125	CcSEcCtD
Lapatinib—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000172	0.00125	CcSEcCtD
Lapatinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.00017	0.00124	CcSEcCtD
Lapatinib—Skin disorder—Prednisone—systemic lupus erythematosus	0.000168	0.00123	CcSEcCtD
Lapatinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000167	0.00122	CcSEcCtD
Lapatinib—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000167	0.00122	CcSEcCtD
Lapatinib—Rash—Cyclosporine—systemic lupus erythematosus	0.000165	0.00121	CcSEcCtD
Lapatinib—Anorexia—Prednisone—systemic lupus erythematosus	0.000165	0.00121	CcSEcCtD
Lapatinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000165	0.00121	CcSEcCtD
Lapatinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000165	0.0012	CcSEcCtD
Lapatinib—Headache—Cyclosporine—systemic lupus erythematosus	0.000164	0.0012	CcSEcCtD
Lapatinib—Anaemia—Methotrexate—systemic lupus erythematosus	0.000164	0.0012	CcSEcCtD
Lapatinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000163	0.00119	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000163	0.00119	CcSEcCtD
Lapatinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000163	0.00119	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Hydrocortisone—systemic lupus erythematosus	0.000163	0.0244	CbGdCrCtD
Lapatinib—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000162	0.00118	CcSEcCtD
Lapatinib—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000161	0.00118	CcSEcCtD
Lapatinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00118	CcSEcCtD
Lapatinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000161	0.00118	CcSEcCtD
Lapatinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.00016	0.00117	CcSEcCtD
Lapatinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000159	0.00116	CcSEcCtD
Lapatinib—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000159	0.00116	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000158	0.00115	CcSEcCtD
Lapatinib—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000157	0.00115	CcSEcCtD
Lapatinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000157	0.00115	CcSEcCtD
Lapatinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000157	0.00115	CcSEcCtD
Lapatinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000157	0.00115	CcSEcCtD
Lapatinib—Insomnia—Prednisone—systemic lupus erythematosus	0.000157	0.00115	CcSEcCtD
Lapatinib—Nausea—Cyclosporine—systemic lupus erythematosus	0.000156	0.00114	CcSEcCtD
Lapatinib—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000155	0.00113	CcSEcCtD
Lapatinib—Cough—Methotrexate—systemic lupus erythematosus	0.000155	0.00113	CcSEcCtD
Lapatinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000155	0.00113	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Hydrocortisone—systemic lupus erythematosus	0.000154	0.0232	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Methylprednisolone—systemic lupus erythematosus	0.000153	0.0231	CbGdCrCtD
Lapatinib—PIK3C2B—Danazol—Hydrocortisone—systemic lupus erythematosus	0.000153	0.023	CbGdCrCtD
Lapatinib—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000153	0.00111	CcSEcCtD
Lapatinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000152	0.00111	CcSEcCtD
Lapatinib—Myalgia—Methotrexate—systemic lupus erythematosus	0.000151	0.0011	CcSEcCtD
Lapatinib—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000151	0.0011	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Betamethasone—systemic lupus erythematosus	0.000151	0.0227	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Dexamethasone—systemic lupus erythematosus	0.000151	0.0227	CbGdCrCtD
Lapatinib—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000151	0.0011	CcSEcCtD
Lapatinib—Rash—Prednisolone—systemic lupus erythematosus	0.00015	0.0011	CcSEcCtD
Lapatinib—Dermatitis—Prednisolone—systemic lupus erythematosus	0.00015	0.0011	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.00015	0.0011	CcSEcCtD
Lapatinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.00015	0.00109	CcSEcCtD
Lapatinib—Fatigue—Prednisone—systemic lupus erythematosus	0.000149	0.00109	CcSEcCtD
Lapatinib—Headache—Prednisolone—systemic lupus erythematosus	0.000149	0.00109	CcSEcCtD
Lapatinib—Constipation—Prednisone—systemic lupus erythematosus	0.000148	0.00108	CcSEcCtD
Lapatinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000148	0.00108	CcSEcCtD
Lapatinib—Rash—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00107	CcSEcCtD
Lapatinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000147	0.00107	CcSEcCtD
Lapatinib—Headache—Hydrocortisone—systemic lupus erythematosus	0.000146	0.00107	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Methylprednisolone—systemic lupus erythematosus	0.000146	0.0219	CbGdCrCtD
Lapatinib—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000145	0.00106	CcSEcCtD
Lapatinib—Infection—Methotrexate—systemic lupus erythematosus	0.000144	0.00105	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Dexamethasone—systemic lupus erythematosus	0.000143	0.0216	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Betamethasone—systemic lupus erythematosus	0.000143	0.0216	CbGdCrCtD
Lapatinib—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000143	0.00104	CcSEcCtD
Lapatinib—Asthenia—Betamethasone—systemic lupus erythematosus	0.000143	0.00104	CcSEcCtD
Lapatinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000142	0.00104	CcSEcCtD
Lapatinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000142	0.00104	CcSEcCtD
Lapatinib—Nausea—Prednisolone—systemic lupus erythematosus	0.000142	0.00103	CcSEcCtD
Lapatinib—Pruritus—Betamethasone—systemic lupus erythematosus	0.000141	0.00103	CcSEcCtD
Lapatinib—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000141	0.00103	CcSEcCtD
Lapatinib—Skin disorder—Methotrexate—systemic lupus erythematosus	0.000141	0.00103	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Triamcinolone—systemic lupus erythematosus	0.00014	0.0211	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Prednisone—systemic lupus erythematosus	0.00014	0.0211	CbGdCrCtD
Lapatinib—Vomiting—Triamcinolone—systemic lupus erythematosus	0.00014	0.00102	CcSEcCtD
Lapatinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000139	0.00102	CcSEcCtD
Lapatinib—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000138	0.00101	CcSEcCtD
Lapatinib—Rash—Triamcinolone—systemic lupus erythematosus	0.000138	0.00101	CcSEcCtD
Lapatinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000138	0.00101	CcSEcCtD
Lapatinib—Anorexia—Methotrexate—systemic lupus erythematosus	0.000138	0.00101	CcSEcCtD
Lapatinib—Rash—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00101	CcSEcCtD
Lapatinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000138	0.00101	CcSEcCtD
Lapatinib—PIK3C2B—Norethindrone—Hydrocortisone—systemic lupus erythematosus	0.000138	0.0207	CbGdCrCtD
Lapatinib—Headache—Triamcinolone—systemic lupus erythematosus	0.000137	0.001	CcSEcCtD
Lapatinib—Headache—Methylprednisolone—systemic lupus erythematosus	0.000137	0.001	CcSEcCtD
Lapatinib—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000137	0.001	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Prednisolone—systemic lupus erythematosus	0.000137	0.0205	CbGdCrCtD
Lapatinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000136	0.000995	CcSEcCtD
Lapatinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000136	0.000995	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisone—systemic lupus erythematosus	0.000133	0.02	CbGdCrCtD
Lapatinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000132	0.000964	CcSEcCtD
Lapatinib—PIK3C2B—Danazol—Prednisone—systemic lupus erythematosus	0.000132	0.0198	CbGdCrCtD
Lapatinib—Insomnia—Methotrexate—systemic lupus erythematosus	0.000131	0.000957	CcSEcCtD
Lapatinib—Nausea—Triamcinolone—systemic lupus erythematosus	0.00013	0.000952	CcSEcCtD
Lapatinib—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00013	0.00095	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisolone—systemic lupus erythematosus	0.00013	0.0195	CbGdCrCtD
Lapatinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000129	0.000943	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000128	0.000933	CcSEcCtD
Lapatinib—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000128	0.000931	CcSEcCtD
Lapatinib—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000127	0.000924	CcSEcCtD
Lapatinib—Vomiting—Betamethasone—systemic lupus erythematosus	0.000127	0.000924	CcSEcCtD
Lapatinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.000126	0.00092	CcSEcCtD
Lapatinib—Rash—Dexamethasone—systemic lupus erythematosus	0.000126	0.000917	CcSEcCtD
Lapatinib—Rash—Betamethasone—systemic lupus erythematosus	0.000126	0.000917	CcSEcCtD
Lapatinib—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000125	0.000916	CcSEcCtD
Lapatinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000125	0.000916	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000125	0.000914	CcSEcCtD
Lapatinib—Fatigue—Methotrexate—systemic lupus erythematosus	0.000125	0.000912	CcSEcCtD
Lapatinib—Headache—Dexamethasone—systemic lupus erythematosus	0.000125	0.000911	CcSEcCtD
Lapatinib—Headache—Betamethasone—systemic lupus erythematosus	0.000125	0.000911	CcSEcCtD
Lapatinib—Asthenia—Prednisone—systemic lupus erythematosus	0.000124	0.000908	CcSEcCtD
Lapatinib—Pruritus—Prednisone—systemic lupus erythematosus	0.000123	0.000896	CcSEcCtD
Lapatinib—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000119	0.000866	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000118	0.000865	CcSEcCtD
Lapatinib—Nausea—Dexamethasone—systemic lupus erythematosus	0.000118	0.000864	CcSEcCtD
Lapatinib—Nausea—Betamethasone—systemic lupus erythematosus	0.000118	0.000864	CcSEcCtD
Lapatinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000115	0.000836	CcSEcCtD
Lapatinib—Vomiting—Prednisone—systemic lupus erythematosus	0.00011	0.000805	CcSEcCtD
Lapatinib—PIK3C2B—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	0.00011	0.0165	CbGdCrCtD
Lapatinib—Rash—Prednisone—systemic lupus erythematosus	0.000109	0.000798	CcSEcCtD
Lapatinib—Dermatitis—Prednisone—systemic lupus erythematosus	0.000109	0.000798	CcSEcCtD
Lapatinib—Headache—Prednisone—systemic lupus erythematosus	0.000109	0.000793	CcSEcCtD
Lapatinib—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000107	0.00078	CcSEcCtD
Lapatinib—Asthenia—Methotrexate—systemic lupus erythematosus	0.000104	0.000759	CcSEcCtD
Lapatinib—Nausea—Prednisone—systemic lupus erythematosus	0.000103	0.000752	CcSEcCtD
Lapatinib—Pruritus—Methotrexate—systemic lupus erythematosus	0.000103	0.000749	CcSEcCtD
Lapatinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	9.91e-05	0.000724	CcSEcCtD
Lapatinib—Vomiting—Methotrexate—systemic lupus erythematosus	9.21e-05	0.000673	CcSEcCtD
Lapatinib—Rash—Methotrexate—systemic lupus erythematosus	9.14e-05	0.000667	CcSEcCtD
Lapatinib—Dermatitis—Methotrexate—systemic lupus erythematosus	9.13e-05	0.000667	CcSEcCtD
Lapatinib—Headache—Methotrexate—systemic lupus erythematosus	9.08e-05	0.000663	CcSEcCtD
Lapatinib—ERBB2—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	9.03e-05	0.0136	CbGdCrCtD
Lapatinib—Nausea—Methotrexate—systemic lupus erythematosus	8.61e-05	0.000629	CcSEcCtD
Lapatinib—ERBB4—Immune System—CD80—systemic lupus erythematosus	2.69e-05	0.000151	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—CDKN1A—systemic lupus erythematosus	2.63e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—systemic lupus erythematosus	2.6e-05	0.000146	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—C3—systemic lupus erythematosus	2.59e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—systemic lupus erythematosus	2.59e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—systemic lupus erythematosus	2.58e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	2.57e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CRP—systemic lupus erythematosus	2.56e-05	0.000144	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—systemic lupus erythematosus	2.56e-05	0.000143	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD80—systemic lupus erythematosus	2.52e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PTPRC—systemic lupus erythematosus	2.49e-05	0.00014	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD80—systemic lupus erythematosus	2.49e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1RN—systemic lupus erythematosus	2.48e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—PPARG—systemic lupus erythematosus	2.47e-05	0.000139	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TLR4—systemic lupus erythematosus	2.46e-05	0.000138	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—systemic lupus erythematosus	2.41e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—systemic lupus erythematosus	2.41e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—systemic lupus erythematosus	2.41e-05	0.000135	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—systemic lupus erythematosus	2.39e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	2.39e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—systemic lupus erythematosus	2.39e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—systemic lupus erythematosus	2.37e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DRB1—systemic lupus erythematosus	2.36e-05	0.000132	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—systemic lupus erythematosus	2.36e-05	0.000132	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TLR9—systemic lupus erythematosus	2.33e-05	0.00013	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40—systemic lupus erythematosus	2.32e-05	0.00013	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TYK2—systemic lupus erythematosus	2.31e-05	0.000129	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTLA4—systemic lupus erythematosus	2.28e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HMGB1—systemic lupus erythematosus	2.28e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TYK2—systemic lupus erythematosus	2.27e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD80—systemic lupus erythematosus	2.27e-05	0.000127	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—JAK1—systemic lupus erythematosus	2.27e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—P2RY12—systemic lupus erythematosus	2.25e-05	0.000126	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNA1—systemic lupus erythematosus	2.24e-05	0.000126	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—JAK1—systemic lupus erythematosus	2.23e-05	0.000125	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—systemic lupus erythematosus	2.19e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RASGRP1—systemic lupus erythematosus	2.19e-05	0.000122	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD79A—systemic lupus erythematosus	2.18e-05	0.000122	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD80—systemic lupus erythematosus	2.18e-05	0.000122	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TYK2—systemic lupus erythematosus	2.17e-05	0.000121	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—systemic lupus erythematosus	2.16e-05	0.000121	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—systemic lupus erythematosus	2.15e-05	0.00012	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCR5—systemic lupus erythematosus	2.15e-05	0.00012	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—systemic lupus erythematosus	2.14e-05	0.00012	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TYK2—systemic lupus erythematosus	2.13e-05	0.000119	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—systemic lupus erythematosus	2.13e-05	0.000119	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	2.13e-05	0.000119	CbGpPWpGaD
Lapatinib—EGFR—Disease—JUNB—systemic lupus erythematosus	2.12e-05	0.000119	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PRL—systemic lupus erythematosus	2.12e-05	0.000119	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.12e-05	0.000119	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCR5—systemic lupus erythematosus	2.12e-05	0.000119	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.1e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—C3—systemic lupus erythematosus	2.1e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TYK2—systemic lupus erythematosus	2.1e-05	0.000118	CbGpPWpGaD
Lapatinib—ERBB2—Disease—NOS3—systemic lupus erythematosus	2.09e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—systemic lupus erythematosus	2.09e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.09e-05	0.000117	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CSK—systemic lupus erythematosus	2.07e-05	0.000116	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—C3—systemic lupus erythematosus	2.07e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	2.06e-05	0.000116	CbGpPWpGaD
Lapatinib—ERBB4—Disease—NOS3—systemic lupus erythematosus	2.06e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—systemic lupus erythematosus	2.06e-05	0.000115	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.03e-05	0.000114	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQA1—systemic lupus erythematosus	2.01e-05	0.000113	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	1.99e-05	0.000111	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDKN1B—systemic lupus erythematosus	1.96e-05	0.00011	CbGpPWpGaD
Lapatinib—EGFR—Disease—PRL—systemic lupus erythematosus	1.96e-05	0.00011	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—systemic lupus erythematosus	1.94e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDKN1B—systemic lupus erythematosus	1.93e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—systemic lupus erythematosus	1.93e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—systemic lupus erythematosus	1.92e-05	0.000108	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TYK2—systemic lupus erythematosus	1.92e-05	0.000107	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—systemic lupus erythematosus	1.91e-05	0.000107	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—systemic lupus erythematosus	1.91e-05	0.000107	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—systemic lupus erythematosus	1.9e-05	0.000106	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NCF2—systemic lupus erythematosus	1.9e-05	0.000106	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—systemic lupus erythematosus	1.89e-05	0.000106	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—systemic lupus erythematosus	1.88e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—LYN—systemic lupus erythematosus	1.88e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQB1—systemic lupus erythematosus	1.88e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NAT2—systemic lupus erythematosus	1.86e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—JAK1—systemic lupus erythematosus	1.86e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.85e-05	0.000103	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—F2—systemic lupus erythematosus	1.84e-05	0.000103	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	1.84e-05	0.000103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—F2—systemic lupus erythematosus	1.82e-05	0.000102	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN1B—systemic lupus erythematosus	1.81e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDKN1A—systemic lupus erythematosus	1.81e-05	0.000101	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.81e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN1B—systemic lupus erythematosus	1.78e-05	9.99e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDKN1A—systemic lupus erythematosus	1.78e-05	9.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL18—systemic lupus erythematosus	1.78e-05	9.98e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD40LG—systemic lupus erythematosus	1.78e-05	9.95e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CD80—systemic lupus erythematosus	1.77e-05	9.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCR5—systemic lupus erythematosus	1.76e-05	9.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—systemic lupus erythematosus	1.76e-05	9.84e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	1.75e-05	9.79e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CD80—systemic lupus erythematosus	1.74e-05	9.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	1.73e-05	9.7e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—systemic lupus erythematosus	1.73e-05	9.7e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EP300—systemic lupus erythematosus	1.72e-05	9.65e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—C3—systemic lupus erythematosus	1.72e-05	9.62e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—systemic lupus erythematosus	1.71e-05	9.56e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EP300—systemic lupus erythematosus	1.7e-05	9.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—JAK1—systemic lupus erythematosus	1.7e-05	9.49e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.68e-05	9.41e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CDKN1A—systemic lupus erythematosus	1.67e-05	9.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—systemic lupus erythematosus	1.66e-05	9.31e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	1.66e-05	9.27e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CDKN1A—systemic lupus erythematosus	1.65e-05	9.22e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCL2—systemic lupus erythematosus	1.64e-05	9.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—systemic lupus erythematosus	1.64e-05	9.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDKN1B—systemic lupus erythematosus	1.63e-05	9.12e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—EP300—systemic lupus erythematosus	1.62e-05	9.07e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCL2—systemic lupus erythematosus	1.62e-05	9.06e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	1.61e-05	9.02e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EP300—systemic lupus erythematosus	1.59e-05	8.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2RA—systemic lupus erythematosus	1.58e-05	8.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—C3—systemic lupus erythematosus	1.57e-05	8.79e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EP300—systemic lupus erythematosus	1.57e-05	8.77e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—JAK1—systemic lupus erythematosus	1.57e-05	8.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDKN1B—systemic lupus erythematosus	1.56e-05	8.76e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—systemic lupus erythematosus	1.53e-05	8.59e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.52e-05	8.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL12—systemic lupus erythematosus	1.52e-05	8.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—F2—systemic lupus erythematosus	1.51e-05	8.45e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CDKN1A—systemic lupus erythematosus	1.5e-05	8.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—systemic lupus erythematosus	1.49e-05	8.36e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TYK2—systemic lupus erythematosus	1.49e-05	8.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JUNB—systemic lupus erythematosus	1.49e-05	8.33e-05	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—systemic lupus erythematosus	1.49e-05	8.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CCR5—systemic lupus erythematosus	1.48e-05	8.31e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TYK2—systemic lupus erythematosus	1.47e-05	8.23e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOS3—systemic lupus erythematosus	1.46e-05	8.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDKN1A—systemic lupus erythematosus	1.44e-05	8.08e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOS3—systemic lupus erythematosus	1.44e-05	8.08e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.44e-05	8.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR4—systemic lupus erythematosus	1.43e-05	8.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DRB1—systemic lupus erythematosus	1.43e-05	8.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—EP300—systemic lupus erythematosus	1.43e-05	8.01e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.42e-05	7.94e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	1.41e-05	7.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—systemic lupus erythematosus	1.41e-05	7.88e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.4e-05	7.86e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—systemic lupus erythematosus	1.38e-05	7.74e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PRL—systemic lupus erythematosus	1.37e-05	7.67e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—systemic lupus erythematosus	1.36e-05	7.63e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CCL2—systemic lupus erythematosus	1.34e-05	7.53e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD80—systemic lupus erythematosus	1.32e-05	7.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—systemic lupus erythematosus	1.31e-05	7.36e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.28e-05	7.17e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.27e-05	7.1e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.25e-05	7e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—systemic lupus erythematosus	1.24e-05	6.95e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—systemic lupus erythematosus	1.22e-05	6.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TYK2—systemic lupus erythematosus	1.22e-05	6.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD80—systemic lupus erythematosus	1.22e-05	6.83e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—systemic lupus erythematosus	1.17e-05	6.58e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.17e-05	6.56e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—systemic lupus erythematosus	1.16e-05	6.48e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.15e-05	6.46e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.15e-05	6.45e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.14e-05	6.4e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—systemic lupus erythematosus	1.13e-05	6.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TYK2—systemic lupus erythematosus	1.12e-05	6.25e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EP300—systemic lupus erythematosus	1.11e-05	6.24e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—systemic lupus erythematosus	1.11e-05	6.22e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EP300—systemic lupus erythematosus	1.1e-05	6.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JAK1—systemic lupus erythematosus	1.1e-05	6.14e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—systemic lupus erythematosus	1.06e-05	5.94e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.05e-05	5.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—systemic lupus erythematosus	1.04e-05	5.85e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—RXRA—systemic lupus erythematosus	1.04e-05	5.84e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—systemic lupus erythematosus	1.04e-05	5.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.04e-05	5.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR5—systemic lupus erythematosus	1.04e-05	5.82e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TYK2—systemic lupus erythematosus	1.03e-05	5.77e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.03e-05	5.75e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—systemic lupus erythematosus	1.03e-05	5.75e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2RA—systemic lupus erythematosus	1.02e-05	5.73e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—systemic lupus erythematosus	1.02e-05	5.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—C3—systemic lupus erythematosus	1.02e-05	5.68e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—NOS3—systemic lupus erythematosus	1.01e-05	5.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—systemic lupus erythematosus	1.01e-05	5.65e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.01e-05	5.64e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.68e-06	5.42e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.54e-06	5.34e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—systemic lupus erythematosus	9.54e-06	5.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1B—systemic lupus erythematosus	9.49e-06	5.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—systemic lupus erythematosus	9.37e-06	5.25e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—systemic lupus erythematosus	9.31e-06	5.22e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—systemic lupus erythematosus	9.28e-06	5.2e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—systemic lupus erythematosus	9.25e-06	5.18e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	9.03e-06	5.06e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.99e-06	5.03e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—F2—systemic lupus erythematosus	8.91e-06	4.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1B—systemic lupus erythematosus	8.76e-06	4.9e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDKN1A—systemic lupus erythematosus	8.75e-06	4.9e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	8.65e-06	4.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CD80—systemic lupus erythematosus	8.54e-06	4.78e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.38e-06	4.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—EP300—systemic lupus erythematosus	8.33e-06	4.66e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CDKN1A—systemic lupus erythematosus	8.08e-06	4.53e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	8.06e-06	4.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL2—systemic lupus erythematosus	7.94e-06	4.45e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	7.87e-06	4.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—EP300—systemic lupus erythematosus	7.69e-06	4.31e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.48e-06	4.19e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—systemic lupus erythematosus	7.3e-06	4.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TYK2—systemic lupus erythematosus	7.21e-06	4.04e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—systemic lupus erythematosus	7.19e-06	4.02e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOS3—systemic lupus erythematosus	7.08e-06	3.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—systemic lupus erythematosus	6.68e-06	3.74e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—systemic lupus erythematosus	6.58e-06	3.69e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.13e-06	3.43e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—systemic lupus erythematosus	6e-06	3.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—systemic lupus erythematosus	5.97e-06	3.34e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—systemic lupus erythematosus	5.92e-06	3.32e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	5.7e-06	3.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—systemic lupus erythematosus	5.68e-06	3.18e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—NOS3—systemic lupus erythematosus	5.66e-06	3.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.66e-06	3.17e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—systemic lupus erythematosus	5.46e-06	3.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—EP300—systemic lupus erythematosus	5.39e-06	3.02e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—systemic lupus erythematosus	5.18e-06	2.9e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	5.13e-06	2.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.1e-06	2.86e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	5.09e-06	2.85e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—systemic lupus erythematosus	5.04e-06	2.82e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	4.97e-06	2.78e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	4.91e-06	2.75e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.85e-06	2.71e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.68e-06	2.62e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	4.58e-06	2.56e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	4.49e-06	2.51e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	4.47e-06	2.5e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	4.38e-06	2.45e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—EP300—systemic lupus erythematosus	4.31e-06	2.41e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	4.27e-06	2.39e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	4e-06	2.24e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3.91e-06	2.19e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	3.73e-06	2.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—systemic lupus erythematosus	3.53e-06	1.98e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	3.33e-06	1.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	3.25e-06	1.82e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.06e-06	1.71e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.75e-06	1.54e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.63e-06	1.47e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.41e-06	1.35e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2e-06	1.12e-05	CbGpPWpGaD
